Dylan Hartley - 27 Jan 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Reporting relationship: Chief Scientific Officer
Issuer ticker: OKUR
Reported as of: 27 Jan 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Jan 2025, 20:33:56 UTC
Prior SEC filing: 08 Oct 2024
Next SEC filing: 03 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Rogan Nunn, by power of attorney

Key filing fact

Dylan Hartley filed Form 4 for OnKure Therapeutics, Inc. (OKUR) on 29 Jan 2025.

Key facts

This page summarizes Dylan Hartley's Form 4 filing for OnKure Therapeutics, Inc. (OKUR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 29 Jan 2025, 20:33.

Change

Previous filing in this sequence was filed on 08 Oct 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OKUR transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +45,000
Change %
Price: $0.000000
Shares after: 45,000
Date: 27 Jan 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 45,000
Exercise price: $5.19
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/48th of the shares subject to the option shall vest on February 27, 2025 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.